<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5239995 Figure_1-A</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Labeling of non-permeabilized (top) and permeabilized (bottom) cells demonstrate that surface labeling does not label internal proteins. GluA2 labeling (green) is visible both on the surface and internally, while DARPP32 labeling (red) is only visible internally.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_1-B</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Top. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures with either no treatment or 20 min 2APB and dantrolene. Bottom. Quantified expression of GluA2 under both conditions, n = 9 replicates of 10 cells each, Student's t test.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_1-C-H</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 1-C-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-H</infon>
    <passage>
      <offset>0</offset>
      <text>C. Representative images of surface GluA1 and DARPP32 expression in striatal neurons from co-cultures with either no treatment, 30 min DHPG, or 2APB and dantrolene pretreatment followed by DHPG. D. Quantified expression of GluA1 under each condition, n = 9 replicates of 10 cells, p &lt; 0.001, ANOVA. E. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures under the same conditions as in C. F. Quantified expression of GluA2 under each condition, n = 12 replicates of 10 cells each, p &lt; 0.001, ANOVA. G. Representative images of surface myc-GluA2, internal myc-GluA2, and DARPP32 expression in striatal neurons from co-cultures under the same conditions as in C. H. Quantified expression of surface myc:total myc under each condition, n = 4 replicates of 10 cells each, p &lt; 0.05, ANOVA. All error bars represent s.e.m. Abbr. A1 = GluA1, A2 = GluA2, D = DARPP32, s-myc = surface myc, i-myc = internal myc, m = merge.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_2-A</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Left. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures treated either for 30 min with DHPG (DHPG) or for 30 min with DHPG and pretreated with Xestospungin C and S107 (XeC/S107 + DHPG). Right. Quantified expression of surface GluA2 under each condition, n = 3 replicates of 10 or 20 cells each, p &lt; 0.0001, Student's t test.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_2-B</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Left. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures treated either for 30 min with DHPG (DHPG), or for 30 min with DHPG and pretreated with S107 (S107 + DHPG), or for 30 min with DHPG and pretreated with Xestospungin C (XeC + DHPG). Right. Quantified expression of surface GluA2 under each condition, n = 4 replicates of 10 cells each, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_2-C-F</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 2-C-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-F</infon>
    <passage>
      <offset>0</offset>
      <text>C. Top. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures under control or 10 min Thapsigargin (TG) treatment. Bottom. Quantified expression of surface GluA2 under each condition, n = 3 replicates of 10 cells each, Student's t test. D. Top. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures with treatment with either no DHPG or with DHPG for 30 min, after 15 min of Thapsigargin. Bottom. Quantified expression of surface GluA2 under each condition, n = 4 replicates of 10 cells each, Student's t test. E. Top. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures with either no DHPG or with DHPG for 30 min, after 5 min of BAPTA. Bottom. Quantified expression of GluA2 under each condition, n = 3 replicates of 10 cells each, p &lt; 0.001, Student's t test. F. Top. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures with either no DHPG or with DHPG for 30 min after 5 min of BAPTA-AM. Bottom. Quantified expression of GluA2 under each condition, n = 3 replicates of 10 cells each, Student's t test. All error bars represent s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_3-A</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Top. Representative image of a radiograph of mature and immature bands of GluA2 after no treatment, DHPG, or 2APB/dan followed by DHPG and incubated with Endo H. Bottom. Quantified graph of the ratio of the mature, endo H insensitive GluA2 band to the total GluA2 for each condition. For DHPG, n = 16; for DHPG + 2APB/dan, n = 11, p &lt; 0.05, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_3-B</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Top. Representative image of a radiograph of mature and immature bands of GluA1 after no treatment, DHPG, or 2APB/dan followed by DHPG and incubated with Endo H. Bottom. Quantified graph of the ratio of the mature, endo H insensitive GluA1 band to the total GluA1 for each condition, For DHPG, n = 4; for DHPG + 2APB/dan, n = 4, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_3-C-D</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C. Representative images of surface GluA2 and DARPP32 expression in striatal neurons from co-cultures with either no DHPG or 30 min DHPG after 15 min of brefeldin A treatment. D. Quantified expression of surface GluA2 under each condition, n = 3 replicates of 10 cells each, Student's t test. All error bars represent s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_4-A</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Top. Representative immunoblots from GluA2 coimmunoprecipitations probed for Sec23 and GluA2 after no treatment, 10 min DHPG, and 2APB/dantrolene followed by 10 min DHPG. Bottom. Quantification of Sec23 normalized to GluA2 under each of these conditions. For 10 min DHPG, n = 8; for 10 min DHPG + 2APB/dan, n = 6, p &lt; 0.05, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_4-B</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Top. Representative immunoblots from GluA2 coimmunoprecipitations probed for Sec23 and GluA2 after no treatment, 10 min DHPG, and and cycloheximide followed by 10 min DHPG. Bottom. Quantification of Sec23 normalized to GluA2 under each of these conditions, For 10 min DHPG, n = 8; for 10 min DHPG + CHX, n = 5, p &lt; 0.05, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_4-C</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Top. Representative immunoblots from GluA2 co-IPs probed for Sec23 and GluA2 after no treatment, 30 min DHPG, and 2APB/dantrolene followed by 30 min DHPG. Bottom. Quantification of Sec23 normalized to GluA2 under each of these conditions. For 30 min DHPG, n = 17; For 30 min DHPG + 2APB/dan, n = 14, p &lt; 0.05, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_4-D</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Top. Representative immunoblots from GluA2 coimmunoprecipitations probed for Sec23 and GluA2 after no treatment, 30 min DHPG, and cycloheximide followed by 30 min DHPG. Bottom. Quantification of Sec23 normalized to GluA2 under each of these conditions. For 30 min DHPG, n = 12; For 30 min DHPG + CHX, n = 11 p &lt; 0.01, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_4-E</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Top. Representative immunoblot demonstrating IgG and GluA2 coIP after no treatment and 30 min DHPG. Bottom. Quantification of Sec23 after subtracting the non-specific signal, n = 3, p &lt; 0.01, Student's t test.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_4-F</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Representative immunoblot of a control coIP that demonstrates the specificity of the GluA2 coIP. All error bars represent s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_5-A-B</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A. Representative immunoblots from GluA2 coIP probed for Sec23, Sec13, and GluA2 after no DHPG, 10, 30, and 60 minutes of treatment with DHPG. B. Graph depicting the kinetics of the association between GluA2 and Sec23 as well as GluA2 and Sec13 after treatment with DHPG for the same points in time as in A. For Sec23, 10 min DHPG, n = 16; 30 min DHPG, n = 15; 60 min DHPG, n = 7, p &lt; 0.0001, ANOVA. For Sec13, 10 min DHPG, n = 7; 30 min DHPG, n = 14; 60 min DHPG, n = 6, p &lt; 0.01, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_5-C</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Representative images of total expression levels of Sec23 (top) and Sec13 (bottom). Expression levels do not change in the presence of DHPG. All error bars represent s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_6-A</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Individual traces of mEPSCs of both control and naspm treated neurons after TTX, TTX + DHPG, and TTX + DHPG + 2APB/dan treatment.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_6-B</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Averaged mEPSCs and an enlarged time scale from cells under the same conditions as A. Traces from cells that were not treated with naspm are in black and naspm treated traces are in grey.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_6-C-D</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C. Average amplitude of mEPSCs (pA) for both control (white bars) and naspm treated (black bars) neurons under each of the conditions, TTX, TTX + DHPG, and TTX + DHPG + 2APB/dantrolene. TTX, n = 26; TTX + naspm, n = 17; TTX + DHPG, n = 18; TTX + DHPG + naspm, n = 23; TTX + DHPG + 2APB/dan, n = 32; TTX + DHPG + 2APB/dan + naspm, n = 36, p &lt; 0.005, ANOVA. D. Average frequency of mEPSC (Hz) for both control (white bars) and naspm treated (black bars) neurons under each of the conditions, TTX, TTX + DHPG, and TTX + DHPG + 2APB/dantrolene. TTX, n = 26; TTX + naspm, n = 12; TTX + DHPG, n = 18; TTX + DHPG + naspm, n = 23; TTX + DHPG + 2APB/dan, n = 32; TTX + DHPG + 2APB/dan + naspm, n = 36, p &lt; 0.0001, ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_6-E-F</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 6-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E. Average amplitude of mEPSCs (pA) for only naspm treated neurons under each of the conditions, TTX, TTX + DHPG, and TTX + DHPG + 2APB/dantrolene. F. Average frequency of mEPSC (Hz) for only naspm treated neurons under each of the conditions, TTX, TTX + DHPG, and TTX + DHPG + 2APB/dantrolene.</text>
    </passage>
  </document>
  <document>
    <id>5239995 Figure_6-G-H</id>
    <infon key="sourcedata_document">2478</infon>
    <infon key="doi">10.15252/embj.201694526</infon>
    <infon key="pmc_id">5239995</infon>
    <infon key="figure">Figure 6-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G. Average rise time of mEPSC (ms) for both control (white bars) and naspm treated (black bars) neurons under each of the conditions, TTX, TTX + DHPG, and TTX + DHPG + 2APB/dantrolene. H. Average decay time of mEPSC (ms) for both control (white bars) and naspm treated (black bars) neurons under each of the conditions, TTX, TTX + DHPG, and TTX + DHPG + 2APB/dantrolene. All error bars represent s.e.m.</text>
    </passage>
  </document>
</collection>
